Copyright
©The Author(s) 2023.
World J Gastroenterol. May 28, 2023; 29(20): 3168-3184
Published online May 28, 2023. doi: 10.3748/wjg.v29.i20.3168
Published online May 28, 2023. doi: 10.3748/wjg.v29.i20.3168
Figure 6 A Heatmap presents the distribution of corresponding risk score and clinical feature in each patient within high and low risk groups.
A: It shows that the patients in low-risk group have more favourable prognosis; B-D: Kaplan-Meier survival curves for patients with low and high risk stratified by the total nomogram score in the entire cohort (B), training cohort (C), and validation cohort (D). aP < 0.05, bP < 0.01, cP < 0.001 was considered significant. ALB: Albumin; MVI: Macrovascular invasion; BUN: Blood urea nitrogen; GPR: Gamma-glutamyl transpeptidase to platelet ratio; PLR: Platelet to lymphocyte ratio; CNLC: China liver cancer staging; CLIP: Cancer of the Liver Italian Program; JIS: Japan integrated staging; BCLC: Barcelona Clinic Liver Cancer; AJCC: American Joint Committee on Cancer.
- Citation: Wu JL, Luo JY, Jiang ZB, Huang SB, Chen GR, Ran HY, Liang QY, Huang MS, Lai LS, Chen JW. Inflammation-related nomogram for predicting survival of patients with unresectable hepatocellular carcinoma received conversion therapy. World J Gastroenterol 2023; 29(20): 3168-3184
- URL: https://www.wjgnet.com/1007-9327/full/v29/i20/3168.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i20.3168